A metabolomic perspective of melatonin metabolism in the mouse

Endocrinology
Xiaochao MaFrank J Gonzalez

Abstract

Metabolism of melatonin (MEL) in mouse was evaluated through a metabolomic analysis of urine samples from control and MEL-treated mice. Besides identifying seven known MEL metabolites (6-hydroxymelatonin glucuronide, 6-hydroxymelatonin sulfate, N-acetylserotonin glucuronide, N-acetylserotonin sulfate, 6-hydroxymelatonin, 2-oxomelatonin, 3-hydroxymelatonin), principal components analysis of urinary metabolomes also uncovered seven new MEL metabolites, including MEL glucuronide, cyclic MEL, cyclic N-acetylserotonin glucuronide, cyclic 6-hydroxymelatonin; 5-hydroxyindole-3-acetaldehyde, di-hydroxymelatonin and its glucuronide conjugate. However, N(1)-acetyl-N(2)-formyl-5-methoxy-kynuramine and N(1)-acetyl-5-methoxy-kynuramine, known as MEL antioxidant products, were not detected in mouse urine. Metabolite profiling of MEL further indicated that 6-hydroxymelatonin glucuronide was the most abundant MEL metabolite in mouse urine, which comprised 75, 65, and 88% of the total MEL metabolites in CBA, C57/BL6, and 129Sv mice, respectively. Chemical identity of 6-hydroxymelatonin glucuronide was confirmed by deconjugation reactions using beta-glucuronidase and sulfatase. Compared with wild-type and CYP1A2-humanized mice, Cyp1a2-null mice ...Continue Reading

References

Jan 1, 1976·Advances in Experimental Medicine and Biology·G DuboisN Baumann
Apr 1, 1990·European Journal of Drug Metabolism and Pharmacokinetics·G FabreJ P Cano
Jan 1, 1988·Journal of Pineal Research·A M LeoneB McKenzie-Gray
Jan 1, 1985·The Journal of Clinical Endocrinology and Metabolism·I M YoungR E Silman
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·H C LiangD W Nebert
Mar 1, 1996·Journal of Pineal Research·J F Peniston-BirdR E Silman
Jan 27, 1999·Biochemical and Biophysical Research Communications·D X TanA M Shepherd
Aug 21, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D X TanR J Reiter
Jan 17, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·D J KennawayR W Moyer
Dec 31, 2002·Toxicology·Frank J Gonzalez
Mar 6, 2003·Pharmacogenetics·Ai-Ming YuFrank J Gonzalez
Jul 31, 2003·Journal of Pineal Research·Eduardo A de AlmeidaPaolo Di Mascio
May 20, 1960·Biochimica Et Biophysica Acta·I J KOPINH WEISSBACH
Oct 3, 2003·Journal of Pineal Research·Stanislav V RozovNikita V Pozdeyev
Oct 3, 2003·Journal of Pineal Research·Pasquale AgozzinoLuisa Tesoriere
Oct 31, 2003·Toxicologic Pathology·Vladimir N Anisimov
Dec 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiaochao MaFrank J Gonzalez
Mar 28, 2006·General and Comparative Endocrinology·Debra J SkeneCostas Ioannides
Apr 26, 2006·Journal of Pineal Research·Xiaochao MaFrank J Gonzalez
Jun 16, 2006·The Journal of Pharmacology and Experimental Therapeutics·Chi ChenFrank J Gonzalez
Jun 20, 2006·Chemical Research in Toxicology·Sarbani GiriFrank J Gonzalez
Oct 4, 2006·Journal of Pineal Research·Jochen H WeishauptHannelore Ehrenreich
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marcella MartignoniRuben de Kanter
Jan 3, 2007·Journal of Pineal Research·Mohamed NaguibPeter A Goldstein
Mar 6, 2007·The Journal of Clinical Psychiatry·P N Suresh KumarNagendra M Singh

❮ Previous
Next ❯

Citations

Mar 18, 2010·Chemical Research in Toxicology·Andrew D PattersonJeffrey R Idle
Apr 8, 2011·Chemical Research in Toxicology·Feng LiXiaochao Ma
Feb 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jianying ShenKeqiang Ye
Dec 31, 2009·Biological Reviews of the Cambridge Philosophical Society·Dun-Xian TanRussel J Reiter
Jan 28, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Feng LiXiaochao Ma
Apr 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Ke LanWei Jia
Aug 9, 2011·Annual Review of Pharmacology and Toxicology·Caroline H JohnsonFrank J Gonzalez
Feb 3, 2015·Drug Metabolism Reviews·Bo Wen, Mingshe Zhu
Dec 18, 2013·Chronobiology International·David J Kennaway
Jul 17, 2009·Pharmacological Reports : PR·Jolanta B ZawilskaJosephine Arendt
Nov 18, 2015·Bioorganic & Medicinal Chemistry Letters·Daniel GlobischKim D Janda
Oct 4, 2014·Reproduction in Domestic Animals = Zuchthygiene·J A Cebrián-PérezT Muiño-Blanco
Jan 1, 2013·Computational and Structural Biotechnology Journal·Chi Chen, Sangyub Kim
Mar 23, 2017·Pharmacology & Therapeutics·Fei LiFrank J Gonzalez
Jan 23, 2014·Journal of Pineal Research·Chaoyue LiXiaochao Ma
Jun 15, 2019·Chronobiology International·David J Kennaway
Oct 29, 2011·Journal of Cellular Physiology·Caroline H Johnson, Frank J Gonzalez
Feb 12, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ke LiuXiaochao Ma
Nov 14, 2019·Cancer Control : Journal of the Moffitt Cancer Center·David J Kennaway
Jul 10, 2020·The Plant Journal : for Cell and Molecular Biology·Kyoungwhan Back
Sep 17, 2009·Metabolic Brain Disease·Sara MontagneseMarsha Y Morgan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.